Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3

View through CrossRef
Nucleotides mediate intercellular communication by activating purinergic receptors and take part in various physiological and pathological processes. Abnormal purinergic signaling plays important roles in malignant progression. P2X7, which belongs to the P2X family of purinergic receptors, is abnormally expressed in various types of malignancies including leukemia. However, its role and molecular mechanism in leukemia have not been elucidated. Here, we analyzed the correlation between P2X7 expression and AML clinical outcome; explored the role and mechanism of P2X7 in AML progression by using mouse acute myeloid leukemia (AML), nude mouse xenograft and patient-derived xenograft models. High levels of P2X7 expression were correlated with worse survival in AML. P2X7 was highly expressed in MLL-rearranged AML. Furthermore, P2X7 accelerated the progression of MLL-rearranged AML by both promoting cell proliferation and increasing leukemia stem cell (LSC) levels. Moreover, P2X7 caused upregulation of Pbx3 accounts for its pro-leukemic effects. The P2X7-Pbx3 pathway might also contribute to the progression of other types of leukemia as well as solid tumors with high levels of P2X7 expression. Our study provides new insights into the malignant progression caused by abnormal purinergic signaling.
Title: P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3
Description:
Nucleotides mediate intercellular communication by activating purinergic receptors and take part in various physiological and pathological processes.
Abnormal purinergic signaling plays important roles in malignant progression.
P2X7, which belongs to the P2X family of purinergic receptors, is abnormally expressed in various types of malignancies including leukemia.
However, its role and molecular mechanism in leukemia have not been elucidated.
Here, we analyzed the correlation between P2X7 expression and AML clinical outcome; explored the role and mechanism of P2X7 in AML progression by using mouse acute myeloid leukemia (AML), nude mouse xenograft and patient-derived xenograft models.
High levels of P2X7 expression were correlated with worse survival in AML.
P2X7 was highly expressed in MLL-rearranged AML.
Furthermore, P2X7 accelerated the progression of MLL-rearranged AML by both promoting cell proliferation and increasing leukemia stem cell (LSC) levels.
Moreover, P2X7 caused upregulation of Pbx3 accounts for its pro-leukemic effects.
The P2X7-Pbx3 pathway might also contribute to the progression of other types of leukemia as well as solid tumors with high levels of P2X7 expression.
Our study provides new insights into the malignant progression caused by abnormal purinergic signaling.

Related Results

Molecular Basis of Menin-MLL Interaction: Implication for Targeted Therapies in MLL Leukemias.
Molecular Basis of Menin-MLL Interaction: Implication for Targeted Therapies in MLL Leukemias.
Abstract Abstract 3775 Poster Board III-711 Chromosomal translocations that affect the proto-oncogene MLL (Mixed Lineage Leukemia) occu...
The MLL PHD Fingers of MLL Block MLL Fusion Protein Mediated Transformation.
The MLL PHD Fingers of MLL Block MLL Fusion Protein Mediated Transformation.
Abstract Mixed Lineage Leukemia (MLL) is a histone H3K4 methyltransferase that is rearranged in both acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL). ...
Abstract B35: Estradiol drives MLL gene fusions in infant acute leukemia
Abstract B35: Estradiol drives MLL gene fusions in infant acute leukemia
Abstract Translocation breakpoints involving the MLL gene linked to Infant Acute Leukemia (IAL) and therapy related acute leukemia (tAL) are tightly clustered betwee...

Back to Top